Study Notes on Informed Consent in Clinical Trials

Clinical Trials and Informed Consent

Overview of Informed Consent

Informed consent has emerged as a fundamental requirement for the ethical conduct of research involving human subjects, primarily recognized during the latter half of the twentieth century. This section discusses the historical development of informed consent, its relationship with treatment consent, the current state of the consent process, and future prospects for improvement.

Historical Context of Informed Consent

Medical research has evolved significantly and can be traced back to systematic investigations such as Lind's controlled trial of treatments for scurvy among British navy sailors in 1747.
Early medical experiments often did not prioritize informed consent. Physicians occasionally advocated for the disclosure of risks and benefits but typically did not inform subjects that they were participating in research often leading to ethical injustices.
A notable early requirement for consent came after scandals, such as the Prussian government mandate for informed consent in the 1890s after a syphilis inoculation scandal.
The first usable consent form was from Walter Reed’s yellow fever studies and significantly resembles contemporary forms despite being short.
The Nuremberg Code (1947) marked a critical juncture in the evolution of informed consent arising from the atrocities of World War II, establishing essential principles, notably the absolute necessity of voluntary consent.

Regulatory Framework

Following the Nuremberg Code, the Declaration of Helsinki was developed in 1964, allowing some clinical research without consent where deemed appropriate by physicians. It indicates a lag in perceiving consent as vital in legitimizing experimental procedures.
The 1970s saw substantial changes, particularly in the United States, spurred by numerous scandals, most notably the Tuskegee syphilis study, leading to the National Research Act of 1974 and subsequent establishment of the Common Rule.
Regulatory requirements today necessitate that consent be accompanied by specific information laid out clearly to potential subjects, including the risks and benefits associated with research participation.

Current State and Efficacy of Informed Consent Process

Consent forms have evolved to be increasingly lengthy and complex, often comprising over 2700 words. For instance, oncology trial consent forms average eleven pages.
Despite their detailed nature, research has shown a negative correlation between the length of consent forms and subjects' comprehension. Studies indicate that many research subjects do not adequately recall essential information related to their study, with common failings in understanding the nature of research, its risks, and potential benefits.
The phenomena known as 'therapeutic misconception', where subjects believe research treatment is standard care, complicates the issue of informed consent, contributing to a persistent gap in achieving well-informed decisions among participants.

Initiatives for Improvement

There is a growing body of literature focused on improving the informed consent process through various methods, such as better-considered consent forms, educational interventions, and enhanced communication strategies during the consent process.
Implementations of educational initiatives such as group teaching sessions and interactive multimedia interventions have shown some promise in enhancing the comprehension of subjects concerning their participation.
Specific approaches such as the 'neutral educator' model have demonstrated improved understanding compared to traditional consent methodologies.

Proposed Rethinking of Informed Consent

The current model emphasizes mere disclosure; however, it fails to ensure subjects genuinely comprehend the information presented.
To make informed consent meaningful, the process should shift from a disclosure model to one focused on education and comprehension.
This involves rethinking who communicates the information—potentially using trained educators rather than researchers themselves to ensure a clearer conveyance of research-related knowledge.

Conclusion

A paradigm shift towards valuing education over mere information disclosure in the consent process is essential to enhance understanding and empower subjects in the decision-making process.
Without fundamental changes, including optimizing communication strategies and reevaluating what information is crucial for participants, the effectiveness of informed consent will remain unrealized.
Informed consent should not only serve as a legal formality but as a genuine commitment to the participant's understanding and ethical engagement in research pursuits.

References

Albala, I., Doyle, M. and Appelbaum, P.S. (2010). The Evolution of Informed Consent Forms for Research: An Evaluation of Changes Over a Quarter Century. IRB: Ethics and Human Research, 32(3), 7-11.
Appelbaum, P.S., Roth, L.H., et al. (1987). False Hopes and Best Data: Consent to Research and the Therapeutic Misconception. Hastings Center Report, 17(2), 20-24.
Department of Health and Human Services (2009). Protection of Human Subjects, 45 Code of Federal Regulations Part 46.
Jones, J. H. (1981). Bad Blood: The Tuskegee Syphilis Experiment.